Popular weight-loss drugs following bariatric surgery may offer additional CV benefits: Study Dr. Kamal Kant Kohli23 May 2025 10:00 PM ISTMedications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events...
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss, reports research Dr. Kamal Kant Kohli17 May 2025 9:15 AM ISTNew research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal...
GLP-1 Drugs May Increase Rejection Risk in Lung Transplant Recipients, Study Suggests Dr. Shravani Dali3 May 2025 7:30 AM ISTA recent study presented at the 2025 International Society for Heart and Lung Transplantation (ISHLT) annual meeting suggests that glucagon-like...
Lean muscle mass loss minimized during weight loss therapy using newer incretin obesity drugs, suggests study Dr. Kamal Kant Kohli11 April 2025 9:15 AM ISTNew research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or...
Anti-obesity drugs benefit kidney transplant recipients with type 2 diabetes: Study Dr. Kamal Kant Kohli15 March 2025 9:00 AM ISTKidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and...
Biocon launches Liraglutide for diabetes, obesity in UK Ruchika Sharma28 Feb 2025 8:26 PM ISTBengaluru: Biocon Limited, an innovation-led global biopharmaceutical company, has announced the launch of its GLP-1 peptide, Liraglutide, for...
Biocon, Zentiva gets Decentralized Procedure approval for generic diabetes, weight management drug in EU Ruchika Sharma24 Dec 2024 11:36 AM ISTBangalore: Biocon and its European partner, Zentiva, have received a Decentralized Procedure (DCP) approval for its complex...
GLP-1 receptor agonists also protect kidneys among patients with diabetes and obesity: Lancet Dr. Kamal Kant Kohli2 Dec 2024 8:15 AM ISTThe biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have...
Bariatric surgery imore cost effective than newer weight loss drugs alone, finds study Dr. Kamal Kant Kohli7 Nov 2024 9:45 PM ISTNewer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at...
Popular weight-loss drugs prove more costly than metabolic and bariatric surgery within one year unravels analysis Dr. Kamal Kant Kohli9 Oct 2024 8:00 PM ISTResearchers from USF Health Morsani College of Medicine in Tampa, FL compared the cumulative cost of pharmacotherapy with GLP-1 agonists to onetime...
Liraglutide Effective in Reducing BMI in Obese Children Aged 6 to 12: SCALE Kids Trial Results Medha Baranwal18 Sept 2024 8:30 PM ISTUSA: In a recent study, liraglutide, a medication primarily used for type 2 diabetes, has demonstrated significant potential in managing obesity in...
Year-Long Weight Reduction with Semaglutide and Liraglutide: Study Reveals Impact of Dosage and Adherence Medha Baranwal16 Sept 2024 9:00 AM ISTUSA: The findings from a recent retrospective cohort study involving 3,389 patients with obesity revealed the effectiveness of semaglutide and...
